✨ Free AI Report
Noven Pharmaceuticals, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Noven Pharmaceuticals, Inc.
Company Research

Noven Pharmaceuticals, Inc.: Business Overview, Financials & Competitive Analysis

Noven Pharmaceuticals is a specialty pharmaceutical company engaged in research, development, manufacture, marketing and sale of prescription pharmaceutical products, with a commitment to advancing patient care throug...

Analyst-debate audio for Noven Pharmaceuticals, Inc.

AskCyborg analysts argue the bull and bear cases for Noven Pharmaceuticals, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Strong

Cyborg Score thesis

Well-positioned specialty pharma with proven patch technology and focused therapeutic areas, but constrained by private...

Read the full analyst-debate transcript →
Industry Pharmaceuticals
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Noven Pharmaceuticals, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Noven Pharmaceuticals, Inc. Overview

Pro stress-test →

Noven Pharmaceuticals is a specialty pharmaceutical company engaged in research, development, manufacture, marketing and sale of prescription pharmaceutical products, with a commitment to advancing patient care through transdermal drug delivery. The company is a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., the world's largest manufacturer of transdermal patches, and serves as Hisamitsu's growth platform for U.S. prescription pharmaceuticals.

Strategic Profile

Pro stress-test →

Noven's commercialized products and product development activities are principally focused in the areas of women's health and mental health, including ADHD and schizophrenia. The company maintains state-of-the art, FDA-approved transdermal manufacturing facilities in Miami with capacity to produce several hundred million patches per year. Noven operates with over 300 colleagues at locations in Miami, Florida and Jersey City, New Jersey.

Competitive Landscape

Pro stress-test →

Noven competes within a marketplace that includes pharmaceutical giants such as Pfizer, among approximately 23 identified competitors. The company's transdermal-focused positioning differentiates it from broader pharma competitors, particularly in specialty applications (women's health, psychiatry/ADHD). Primary competition comes from established transdermal and oral delivery alternatives in mental health and HRT markets.

Industry Context

Noven Pharmaceuticals, Inc. operates in Pharmaceuticals.

Key facts

Founded: 1987 · Headquarters: Miami, Florida · Employees: 300+

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Noven Pharmaceuticals, Inc..

  • Noven broke ground in April 2026 on a new state-of-the-art Quality Control Laboratory Building exceeding 24,000 sqft, designed to increase output capacity to meet growing patient demands.
  • Noven commercializes products through Noven Therapeutics, LLC, with Grove Pharmaceuticals serving as its generic division.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • April 2026Broke ground on new state-of-the-art Quality Control Laboratory Building with 24,000+ sqft capacity expansion
  • October 2022Presented data on transdermal dextroamphetamine wear-times and pediatric-to-adult efficacy extrapolation
  • +1 moreTrack every material event for Noven Pharmaceuticals, Inc. as it happens. Explore monitoring →
Get alerted when Noven Pharmaceuticals, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

PfizerLarge integrated pharmaceutical company with broad therapeutic portfolio→Hisamitsu PharmaceuticalParent company and world's largest transdermal patch manufacturer→Mylan/ViatrisGeneric and specialty pharma competitor with psychiatric products→

Compare Noven Pharmaceuticals, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Noven Pharmaceuticals, Inc. operates in Pharmaceuticals. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals research →
NEW · MCP server

Ask your AI assistant about Noven Pharmaceuticals, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Noven Pharmaceuticals, Inc. and its top competitor on Cyborg Score”
“What did Noven Pharmaceuticals, Inc. do this quarter?”
“Is Noven Pharmaceuticals, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Noven Pharmaceuticals, Inc. do?+
Noven Pharmaceuticals is a specialty pharmaceutical company engaged in research, development, manufacture, marketing and sale of prescription pharmaceutical products, with a commitment to advancing patient care throug...
What is Noven Pharmaceuticals, Inc.'s Cyborg Score?+
Noven Pharmaceuticals, Inc. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Noven Pharmaceuticals, Inc.'s main competitors?+
Named competitors include Pfizer, Hisamitsu Pharmaceutical, Mylan/Viatris. The full competitive landscape is in the AskCyborg report.
How can I get the full Noven Pharmaceuticals, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Noven Pharmaceuticals, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Noven Pharmaceuticals, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Pharmaceuticals research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Novartis AG7Recordati Industria Chimica e Farmaceutica SpA6CSPC Innovation Pharmaceutical Co., Ltd.7Pfizer Inc.